Harry Lam Email & Phone Number
Founder and CEO
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Harry Lam Location
- Taipei City, Taiwan
Harry Lam Work
- Founder and CEO @ FAST Cell Therapy, Inc. (February 2023 - Present)
- Senior Technology Advisor @ (July 2024 - June 2025)
- CTO, EVP Technical Operations @ (May 2022 - June 2024)
- CTO, EVP Technical Operations @ (September 2018 - May 2022)
- Director, Head of Therapeutics Technical Operations @ (April 2017 - September 2018)
- CTO, VP CMC Development @ Affinita Biotech (June 2016 - March 2017)
- VP, Head of Manufacturing, Biologics @ (August 2015 - June 2016)
- Vice President, Manufacturing Development and Technical Operations @ Progenitor Cell Therapy (October 2014 - August 2015)
- Senior Vice President, Technical Operations @ KaloBios (January 2014 - October 2014)
- Vice President, Head of Manufacturing @ Shire Regenerative Medicine (March 2013 - January 2014)
- Head Commercial Drug Substance CMO @ (May 2012 - March 2013)
- Senior Director, Global Biologics Drug Substance Manufacturing Science and Technology @ (April 2010 - May 2012)
- Director, Manufacturing and Technology @ Roche Singapore Technical Operation (July 2007 - April 2010)
- Director, Biochemical Technology @ (November 2003 - July 2007)
- Director, Biochemical Manufacturing Operations @ (April 2003 - November 2003)
- Associate Director, Fermentation Operations @ (January 2001 - April 2003)
- Group Leader, Manufacturing Science and Technology @ (January 1998 - January 2001)
Harry Lam Education
- Rensselaer Polytechnic Institute
PhD (Chemical Engineering)
- University of Birmingham
BSc (Chemical Engineering)
Harry Lam Skills
- Validation
- Technology Transfer
- Process Simulation
- FDA
- Manufacturing
- Biopharmaceuticals
- Pharmaceutical Industry
- Biochemistry
- Leadership
- Cross-functional Team Leadership
- Biotechnology
- Process Improvement
- GMP
- Operational Excellence
- R&D
- Fermentation
- Process Engineering
- Sop
- Change Control
- Purification
- 21 CFR Part 11
- Chromatography
- GLP
- Medical Devices
- Commercialization
- Quality System
- Protein Purification
- Drug Development
- Vaccines
- CAPA
- V&V
- Computer System Validation
- Lifesciences
- LIMS
- GxP
- HPLC
- Protein Chemistry
- Life Sciences
- Data Validation
- Simulation
- Business Development
- Project Management
- SQL
- Requirements Analysis
- Cross Functional Team Leadership
- Technology
Harry Lam Summary
- Harry Lam, based in Taipei City, Taiwan, is currently a Founder and CEO at FAST Cell Therapy, Inc.. Harry Lam brings experience from previous roles at JW Therapeutics 药明巨诺, Acepodia and 23andMe. Harry Lam holds a PhD in Chemical Engineering @ Rensselaer Polytechnic Institute. With a robust skill set that includes Validation, Technology Transfer, Process Simulation, FDA, Manufacturing and more. Harry Lam has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Harry Lam?
Find contact details for 700 million professionals.
Others Named Harry Lam
Harry Lam
Vice President of Risk Operations and Change Management
Greenwich, CT, US
Harry Lam
CEO and Co-Owner
San Diego, CA, US
Harry Lam
Architect
San Francisco, CA, US
Harry Lam
Chief Executive Officer
Hong Kong
Harry Lam
Senior Analyst, Enterprise Solution Delivery
Richmond Hill, ON, CA
Harry Lam
General Manager - Asia
Hong Kong
Harry Lam
AVP HNW Operations
Hong Kong
Harry Lam
Nework Planner
Chicago, IL, US
Harry Lam
Senior Data Analyst
Rockville, MD, US
Harry Lam
Backend Engineer
United Kingdom
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co